Magnetically modulated therapeutic systems

International Journal of Pharmaceutics

Volumn 277, Issue 1-2, 2004, Pages 19-24

  Hafeli U O ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cell separation; Chemotherapy; Contrast agent; Liver tumor; Magnetic microspheres; Magnetic targeting

Indexed keywords

ALBUMIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C1S; CONTRAST MEDIUM; DEXTRAN; DOXORUBICIN; DRUG CARRIER; EPIRUBICIN; ETOPOSIDE; FERUMOXSIL; INDIUM 111; IODINE 125; IRON; IRON OXIDE; LIPOSOME; MICROSPHERE; MITOMYCIN C; MITOXANTRONE; NANOPARTICLE; OCTREOTIDE; OXALIPLATIN; PACLITAXEL; PEPTIDE; POLYLACTIC ACID; RADIOACTIVE MATERIAL; RADIOISOTOPE; RHENIUM 188; SUPERPARAMAGNETIC IRON OXIDE; TUMOR NECROSIS FACTOR ALPHA; YTTRIUM 90;

ARTIFICIAL EMBOLISM; BEAM THERAPY; CANCER; CANCER RADIOTHERAPY; CELL SEPARATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DIAGNOSTIC VALUE; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HYPERTHERMIC THERAPY; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TUMOR; MAGNETIC FIELD; MAGNETISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; SIDE EFFECT; TABLET FORMULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIVER NEOPLASMS; MAGNETICS;

EID: 2442683843     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.03.002     Document Type: Conference Paper

References (35)

1. Alexiou C., Arnold W., Klein R.J. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60:2000;6641-6648
2. Bosnes, M., Deggerdal, A., Rian, A., Korsnes, L., Larsen, F., 1997. Magnetic separation in molecular biology. In: Häfeli, U.O., Schütt, W., Teller, J., Zborowski, M. (Eds.), Scientific and Clinical Applications of Magnetic Carriers. Plenum Press, New York, pp. 269-285.
3. Chan D.C.F., Kirpotin D.B., Bunn P.A. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer. J. Magn. Magn. Mater. 122:1993;374-378
4. Chen H., Langer R. Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm. Res. 14:1997;537-540
5. Dailey J.P., Phillips J.P., Li C., Riffle J.S. Synthesis of silicone magnetic fluid for use in eye surgery. J. Magn. Magn. Mater. 194:1999;140-148
6. Edelman E.R., Langer R. Optimization of release from magnetically controlled polymeric drug release devices. Biomaterials. 14:1993;621-626
7. Farag S.S. Therapeutic applications of immunomagnetic cell selection: a review. Eur. Cells Mater. 3:2002;37-40
8. Flores G.A., Liu J. In vitro blockage of a simulated vascular system using magnetorheological fluids as a cancer therapy. Eur. Cells Mater. 3:2002;9-11
9. Gilchrist R.K., Medal R., Shorey W.D., Hanselman R.C., Parrott J.C., Taylor C.B. Selective inductive heating of lymph nodes. Ann. Surg. 146:1957;596-606
10. Goodwin S. Magnetic targeted carriers offer site-specific drug delivery. Oncol. News Int. 9:2000;22
11. Gupta P.K., Hung C.T. Magnetically controlled targeted micro-carrier systems. Life Sci. 44:1989;175-186
12. Häfeli, U., Schütt, W., Teller, J., Zborowski, M., 1997. Scientific and Clinical Applications of Magnetic Carriers, first ed. Plenum Press, New York.
13. Häfeli, U.O., 2001. Radioactive magnetic microspheres. In: Arshady, R. (Ed.), Microspheres, Microcapsules & Liposomes: Magneto- and Radio-Pharmaceuticals, vol. 3. Citus Books, London, Chapter 18, pp. 559-584.
14. Häfeli, U.O., Pauer, G.J., Roberts, W.K., Humm, J.L., Macklis, R.M., 2001. Magnetically targeted microspheres for intracavitary and intraspinal Y-90 radiotherapy. In: Häfeli, U., Pauer, G., Failing, S., Tapolsky, G. (Eds.), Radiolabeling of Magnetic Particles with Rhenium-188 for Cancer Therapy. J. Magn. Magn. Mater. 225, 73-78.
15. Hilal S.K., Michelsen W.J., Driller J., Leonard E. Magnetically guided devices for vascular exploration and treatment. Radiology. 113:1974;529-540
16. Johnson J., Kent T., Koda J., Peterson C., Rudge S., Tapolsky G. The MTC technology: a platform technology for the site-specific delivery of pharmaceutical agents. Eur. Cells Mater. 3:2002;12-15
17. Jones S.K., Winter J.G. Experimental examination of a targeted hyperthermia system using inductively heated ferromagnetic microspheres in rabbit kidney. Phys. Med. Biol. 46:2001;385-398
18. Jordan A., Wust P., Fahling H., John W., Hinz A., Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia. 9:1993;51-68
19. Jordan A., Scholz R., Maier-Hauff K. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 225:2001;118-126
20. Kost J., Wolfrum J., Langer R. Magnetically enhanced insulin release in diabetic rats. J. Biomed. Mater. Res. 21:1987;1367-1373
21. Kronick P.L., Campbell G.L., Joseph K. Magnetic microspheres prepared by redox polymerisation used in a cell separation based on gangliosides. Science. 200:1978;1074-1076
22. Kuznetsov A.A., Shlyakhtin O.A., Brusentsov N.A., Kuznetsov O.A. "Smart" mediators for self-controlled inductive heating. Eur. Cells Mater. 3:2002;75-77
23. Langer R., Hsieh D.S.T., Rhine W., Folkman J. Control of release kinetics of macromolecules from polymers. J. Membr. Sci. 7:1980;333-350
24. Lübbe A.S., Bergemann C., Riess H. Clinical experiences with magnetic drug targeting: A phase I study with 4′- epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 56:1996;4686-4693
25. Lübbe A.S., Alexiou C., Bergemann C. Clinical applications of magnetic drug targeting. J. Surg. Res. 95:2001;200-206
26. Meyers, P.H., Cronic, F., Nice, C.M., 1963. Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent. Am. J. Roentgenol. Radium Ther. Nucl. Med. 90, 1068-1077.
27. Meza, M., 1997. Application of magnetic particles in immunoassays. In: Häfeli, U.O., Schütt, W., Teller, J., Zborowski, M. (Eds.), Scientific and Clinical Applications of Magnetic Carriers. Plenum Press, New York, pp. 303-309.
28. Moroz P., Jones S.K., Gray B.N. Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model. J. Surg. Oncol. 80:2002;149-156
29. Saini, S., Stark, D.D., Hahn, P.F., Wittenberg, J., Brady, T.J., Ferrucci, J.T., 1987. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162, 211-216.
30. Scherer F., Anton M., Schillinger U. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy. 9:2002;102-109
31. Turner R.D., Rand R.W., Bentson J.R., Mosso J.A. Ferromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new technique. J. Urol. 113:1975;455-459
32. Widder K.J., Senyei A.E., Ranney D.F. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Adv. Pharmacol. Chemother. 16:1979;213-271
33. Widder D.J., Greif W.L., Widder K.J., Edelman R.R., Brady T.J. Magnetite albumin microspheres: a new MR contrast material. AJR. 148:1987;399-404
34. Widder K.J., Morris R.M., Poore G.A., Howards D.P., Senyei A.E. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur. J. Cancer Clin. Oncol. 19:1983;135-139
35. Wu C.B., Wei S.L., He S.M. Studies on adriamycin magnetic gelatin microspheres. J. Clin. Pharm. Sci. 4:1995;1-6